Overview

Clinical Study of Utidelone Injection in Patients With Advanced Non-small Cell Lung Cancer（NSCLC）

Status:
Recruiting
Trial end date:
2021-09-30
Target enrollment:
Participant gender:
Summary
To assess the effectiveness and safety of utidelone injection in patients with advanced or metastatic NSCLC as a phase II trial
Phase:
Phase 2
Details
Lead Sponsor:
Beijing Biostar Technologies, Ltd
Collaborator:
Chengdu Biostar Pharmaceuticals, Ltd